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Abstract 
Purpose: To investigate the effect of miR-9 on the proliferation, differentiation and migration of human 
neural stem cells (NSCs).  
Methods: The expression of miR-9 was investigated by quantitative real-time polymerase chain 
reaction (RT-PCR). Cell proliferation was assessed by cell counting kit-8 (CCK8) assay, while cell 
migration was studied by Transwell assay. The effect of miR-9 on differentiation of NSCs was 
investigated by western blot analysis of key differentiation marker proteins. Protein expression was 
determined by western blotting. 
Results: Transfection and over-expression of miR-9 in NSCs significantly enhanced the proliferation of 
NSCs (p < 0.05) in a time-dependent manner, as was evident from CCK8 assay data. MiR-9 over-
expression caused down-regulation of Nestin and SOX-2, and up-regulation of Tuj-1 and MAP-2. The 
migration of NSCs was 37 % in the cells transfected with empty vector, compared to 68 % in the cells 
transfected with miR-9. This effect of miR-9 on cell migration was accompanied by up-regulation of 
matrix metallopeptidase 9 (MMP-9) and matrix metallopeptidase 2 (MMP-2). 
Conclusion: These results show that miR-9 promotes the proliferation, differentiation and migration of 
NSCs, and thus may be an important drug target for the generation of NSCs. 
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Neural stem cells (NSCs) are basically 
undifferentiated cells with the capacity to divide 
and self-renew. They also develop into neuronal 
and glial cells [1-3]. Although (NSCs have 
received considerable attention and have been 
thoroughly studied, the molecular mechanisms 
involved in their proliferation and differentiation 
have not been thoroughly studied. MicroRNAs 
are small RNA molecules that do not code for 
proteins [4,5]. They have been reported to play 
diverse roles. It is believed that the expressions 
of thousands of genes in humans are regulated 
by microRNAs. The main processes regulated by 
microRNAs involve the proliferation and 
progression of several types of cells [6].  
 
Recently, it was reported that miRNAs are 
involved in the differentiation of mouse 
embryonic stem cells (ES). Studies have shown 
that R-124 (one of the miRNAs) is highly 
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expressed during differentiation of ES, and that it 
promotes the differentiation of embryonic tumour 
P19 cells of mice in vitro [7,8]. Similar to miR-
124, miR-9 has also been reported to be 
upregulated during the differentiation of several 
mouse neural stem cells [9]. 
 
In the present study, the expression of human 
NSCs was studied, as well as the effect of miR-9 
over-expression on the proliferation, 
differentiation and migration of human NSCs. 
This was with a view to elucidating the potential 
of miR-9 in improving the proliferation and 




Human neural stem cells [Gibco® Human Neural 
Stem Cells (H9-Derived)] were obtained from 
Thermos Fisher. The cells were kept in DMEM 
F12 medium containing L-glutamine (1 mM), N2 
supplement (Gibco-BRL), 20 ng/mL each of EGF 
and FGF-2, and 50 ng/mL heparin. To induce cell 
differentiation, the cells were cultured in DMEM 
F12 medium with N2 supplement containing 1μM 




The upstream and downstream flanking 
sequences of miR-9 were amplified with genomic 
PCR. This was followed by cloning in pMSCv-pur 
vector. Thereafter, the vector containing miR-9 
and the empty vector (negative control) were 
transfected into NSCs cells with help of FuGENE 
HD (Promega) as per the manufacturer’s 
protocol. The transfection efficacy was checked 
by 5’-FAM labelled miR-9 using fluorescence 
microscopy. 
 
Assessment of expression by quantitative 
RT-PCR 
 
For isolation of RNA, RNeasy RNA isolation kit 
was used as per the instructions of the 
manufacturer. Thereafter, cDNA was synthesized 
with the help of RevertAid cDNA synthesis kit 
(Fermentas) following the manufacturer’s 
protocol. In the RT-PCR assay, the cDNA was 
diluted 20 times and qRT-PCR was carried out in 
3 replicates in ABI StepOne Real time using 
SYBR Green Master Mix (Fermentas). Relative 
quantification method (ΔΔ-CT) was employed to 
determine quantitative variation in the samples.  
GAPDH was used as positive control. 
 
Cell proliferation assay 
 
The viability of the human NSCs, CCK-8 assay 
was used. The cells were collected at 24, 48, 72 
and 96 h after transfection with miR-9 mimics or 
empty vector, and subjected to CCK-8 assay. 
Cell viability was assayed by cell numbering kit-
18 (Dojondo, Japan) in accordance with the 
manufacturer’s guidelines. 
 
Cell migration assay 
 
Transwell assay was used to investigate the 
effect of miR-9 on NSC migration. The cells were 
seeded in twenty-four well plates using 
polycarbonate membranes with 8-m pores. The 
NSCs in DMEM F12 medium (100 µL) were 
placed at a density of 1 × 106cells/mL in the 
upper chamber of the transwell assembly, while 
600 µL of DMEM F12 medium supplemented 
with FBS (1 %) and SCF (100 ng/mL) was placed 
in the lower chamber. The cells were then 
incubated for 10 h at 37 ○C. Non-migrating cells 
were removed by scrapping the upper surfaces 
of the membranes and washed in PBS. The 
membranes were thereafter fixed and stained 
with haematoxylin and eosin (H & E). 
 
Western blotting analysis 
 
Total protein from the neural stem cells was 
isolated in RIPA lysis buffer. The proteins were 
quantified by BSA protein assay kit, and equal 
amounts of protein extract from each group (miR-
9 and empty vector transfected NSCs) were run 
on SDS-PAGE and then transferred to a 
polyvinylidene fluoride membrane. This was 
followed by blocking with 5% non-fat milk and 
incubation at room temperature for 1h. 
Thereafter, the membranes were incubated with 
appropriate primary antibodies overnight at 4 °C. 
This was followed by washing in washing buffer 
and incubation for 1 h with the secondary 
antibody. The protein bands of interest were 





The experiments were carried out in triplicate 
and the results are presented as mean ± SD. 
Student’s t-test was used for statistical analysis 
using GraphPad Prism software, version 7 
(GraphPad Software Inc, La Jolla CA, USA). 




Transfection of NSCs and expression of miR-
9 
 
It was observed that the expression of miR-9 was 
about 6.3 times higher in the miR-9 transfected 
cells, when compared to NSCs transfected with 
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empty vector (Figure 1). The transfection efficacy 
was further checked by fluorescence microscopy 
and the results showed 76 % transfection (Figure 
2). Given these successful transfection results, 
further experiments were designed accordingly. 
 
Effect of miR-9 on proliferation of NSCs 
 
The effect of miR-9 transfection on proliferation 
of NSCs was evaluated through CCK8 assay. 
The results showed that transfection of NSCs 
with miR-9 led to significant and time-dependent 
enhancement of the proliferation of NSCs (Figure 
3). 
 
Effect of miR-9 on the differentiation of NSCs 
 
The results of western blot analysis showed that 
miR-9 over-expression in NSCs caused 
significant down-regulation of Nestin and SOX-2, 
and significant increases in the expressions of 
Tuj-1 and MAP-2 (Figure 4). These results show 
that miR-9 promoted the differentiation of NSCs. 
 
Effect of miR-9 on the migration of NSCs 
 
Results from transwell assay showed that over-
expression of miR-9 in NSCs enhanced their 
capacity to migrate. There was 32 % cell 
migration in the NSCs transfected with empty 
vector, relative to 68 % cell migration in the 
NSCs transfected with miR-9-containing vector 
(Figure 5). To further validate these results, it 
was observed that the expressions of MMP-2 
and MMP-9 were upregulated in the NSCs 
transfected with miR-9 (Figure 6). Taken 
together, these results clearly indicate that miR-9 
enhanced the migration of NSCs. 
 
 
Figure 1: Relative expression of miR-9 in miR-9-
transfected NSCs, and empty vector-transfected 
NSCs. Results are expressed as mean ± SD of three 




Figure 2: Transfection efficacy via fluorescence 
microscopy. Each experiment was carried out in 




Figure 3: Relative cell viability of NSCs transfected 
with miR-9 or empty vector. The experiments were 
carried out in triplicates, and results are expressed as 
mean ± SD 
 
 
Figure 4: Western blot showing the expressions of 
Nestin, SOX-2, Tuj-1 and MAP-2 in empty vector- and 
miR-9-transfected NSCs 
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Figure 5: Cell migration capacity of NSCs transfected 
with empty vector or miR-9 as determined by transwell 
migration assay. Each experiment was carried out in 
triplicate, and the results are expressed as mean ± 




Figure 6: Western blots showing the expressions of 
MMP-9 and MMP-2 in empty vector- and miR-9-




Human NSCs are self-renewing, multipotent cells 
capable of giving rise to the main phenotypes of 
the nervous system [10]. Several studies have 
been carried out on the potential clinical 
applications of NSCs [11]. It has been reported 
that NSCs could be beneficial in the treatment of 
neurological disorders such brain trauma and 
spinal cord injury [2]. Whereas the functional 
properties of NSCs have been studied to some 
extent [13], the mechanisms that govern their 
renewal, differentiation and migration have not 
been fully explored. 
 
MicroRNAs have been reported to play vital roles 
in a diversity of cellular processes by regulating 
the expression of a number of genes. They are 
considered as therapeutic targets for the 
treatment of cancer, and they are currently 
thought to be important for understanding the 
mechanism behind the renewal and 
differentiation of NSCs [14,15]. MiR-9 has been 
previously reported to be significantly expressed 
in NSCs. In the current study, the effect of miR-9 
over-expression on proliferation, differentiation 
and migration of NSCs was investigated. The 
results showed that miR-9 over-expression in 
NSCs enhanced their proliferation in a time-
dependent manner. These results are in 
agreement with a previous study in which miR-9 
was found to regulate the proliferation of cancer 
cells [16]. In addition, it was observed that miR-9 
over-expression in NSCs promoted their 
differentiation by inducing changes in the 
expression of several marker proteins for cell 
differentiation: the protein expressions of Nestin 
and SOX-2 were decreased, while the 
expressions of Tuj-1 and MAP-2 were 
significantly increased. 
 
These observations suggest that miR-9 probably 
regulated the differentiation of NSCs by 
controlling the expressions of these proteins. 
These findings are in agreement with previous 
reports in which microRNAs were shown to 
regulate the expressions of Nestin, SOX-2, Tuj-1 
and MAP-2 [17]. Results from transwell migration 
assay revealed that miR-9 increased the 
migration potential of NSCs. The increase in 
migration was also associated with enhanced 
expressions of MMP-9 and MMP-2. Taken 
together, these results provide new and useful 
insights for understanding the mechanisms that 




The findings of this study demonstrate that miR-9 
regulates the proliferation, differentiation and 
migration of NSCs. These results are considered 
helpful for unravelling some of the molecular 
mechanisms that regulate the proliferation and 
differentiation of NSCs. Thus, further studies on 
miR-9 will enhance knowledge on the molecular 
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